Drugs - HealthQuill

Bristol Myers Squibb’s end-phase trial to test a drug for treating a heart condition, where the muscle of the heart's main pumping chamber becomes abnormally thickened, has failed to meet its goals.

Bristol Myers’ test drug to treat a type of heart disease fails to meet goals

HQ Team April 15, 2025: Bristol Myers Squibb’s end-phase trial to test a drug for treating a heart condition, where the muscle of.

by HealthQuill
April 15, 2025
0 Comments

A new pandemic like Covid-19 is “not a theoretical risk, it is an epidemiological certainty,” said the World Health Organization’s Director-General, Dr Tedros Adhanom Ghebreyesus.

Climate Drugs Health

A new pandemic like Covid-19 is ‘epidemiological certainty’: WHO

HQ Team April 13, 2025: A new pandemic like Covid-19 is “not a theoretical risk, it is an epidemiological certainty,” said the World.

by HealthQuill
April 13, 2025
0 Comments

Novo Nordisk will invest 6.4 billion reais ($1.05 billion) in Brazil’s Monte Claros to expand its production of injectable treatments for people living with obesity and chronic diseases.

Drugs Medical Pharma

Novo Nordisk to invest $1.05b in Monte Claros facility in Brazil

HQ Team April 10, 2025: Novo Nordisk will invest 6.4 billion reais ($1.05 billion) in Brazil’s Monte Claros to expand its production of.

by HealthQuill
April 10, 2025
0 Comments

The United Nations has warned that “unprecedented” global aid cuts could derail a three-year trend of a 40% decline in maternal deaths as one maternal death occurred every two minutes worldwide in 2023.

Drugs Health Pharma

Maternal mortality rates may fail UN goal, global aid cuts the main culprit

HQ Team April 9, 2025: The United Nations has warned that “unprecedented” global aid cuts could derail a three-year trend of a 40%.

by HealthQuill
April 9, 2025
0 Comments

AstraZeneca’s combination drug for the treatment of adults with resectable non-small cell lung cancer has got approval from the European Union.

Drugs Health Pharma

AstraZeneca’s lung cancer drug combination gets EU approval

HQ Team April 4, 2025: AstraZeneca’s combination drug for the treatment of adults with resectable non-small cell lung cancer has got approval from.

by HealthQuill
April 4, 2025
0 Comments

Daiichi Sankyo and AstraZeneca’s treatment for breast cancer, Enhertu, has been approved as a monotherapy in the European Union, the companies announced.

Drugs Medical Pharma

EU green lights AstraZeneca, Daiichi’s treatment for breast cancer

HQ Team April 4, 2025: Daiichi Sankyo and AstraZeneca’s treatment for breast cancer, Enhertu, has been approved as a monotherapy in the European.

by HealthQuill
April 4, 2025
0 Comments

Amgen Inc.’s treatment for adults living with immune-mediated inflammatory conditions was granted regulatory approval by the US Food and Drug Administration, according to a statement.

Drugs Health Medical

Amgen gets US approval to treat immunoglobulin G4-related disease

HQ Team April 4, 2025: Amgen Inc.’s treatment for adults living with immune-mediated inflammatory conditions was granted regulatory approval by the US Food and.

by HealthQuill
April 4, 2025
0 Comments

The US Food and Drug Administration has rejected the biotechnology company Aldeyra Therapeutics Inc’s investigational drug for treating dry eyes, over concerns with the data from the trial.

Drugs Health Medical

Aldeyra Therapeutics’ dry eye treatment rejected by USFDA

HQ Team April 3, 2025: The US Food and Drug Administration has rejected the biotechnology company Aldeyra Therapeutics Inc’s investigational drug for treating.